Chaitanya Chakravarthi Gali

Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease

Jayasankar Kosaraju, Chaitanya Chakravarthi Gali, Rizwan Basha Khatwal et al. · Neuropharmacology · 2013 · 187 citations

Induced Alzheimer, Alzheimer's Disease, Biochemistry +8

Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice

Chaitanya Chakravarthi Gali, Elham Fanaee‐Danesh, Martina Zandl‐Lang et al. · Molecular and Cellular Neuroscience · 2019 · 84 citations · Full text

Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells

Martina Zandl‐Lang, Elham Fanaee‐Danesh, Yidan Sun et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2017 · 67 citations

App Processing, Alzheimer's Disease, Blood–brain Barrier +11

Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells

Elham Fanaee‐Danesh, Chaitanya Chakravarthi Gali, Jelena Tadić et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2019 · 48 citations

Alzheimer's Disease, Medicine, Dementia +11

Gestational diabetes mellitus modulates cholesterol homeostasis in human fetoplacental endothelium

Yidan Sun, Susanne Kopp, Jasmin Strutz et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2018 · 43 citations

Metabolic Syndrome, Physiology, Diabetes +11